---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-073957"
form_type: "8-K"
ticker: "SLS"
cik: "0001390478"
company_name: "SELLAS Life Sciences Group, Inc."
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:45:25.442658+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# SELLAS Life Sciences stockholders re-elect two Class II directors and ratify auditor at 2024 annual meeting

## Summary
- Scheinberg and Kalin re-elected as Class II directors (8.6M/8.8M for; 18.7M broker non-votes).
- Ratified Moss Adams LLP as FY2024 auditor: 27.8M for, 1.7M against, 0.5M abstain.
- Advisory 'say-on-pay' passed: 6.0M for, 4.8M against, 0.6M abstain; 18.7M broker non-votes.
- Quorum: 30.0M shares (51.95%) represented at meeting.

## SEC filing metadata
- accession: 0001104659-24-073957
- form_type: 8-K
- ticker: SLS
- cik: 0001390478
- company_name: SELLAS Life Sciences Group, Inc.
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1390478/000110465924073957/0001104659-24-073957-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1390478/000110465924073957/tm2417795d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-073957
- JSON: https://secwatch.observer/filing/0001104659-24-073957.json
- Plain text: https://secwatch.observer/filing/0001104659-24-073957.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.